Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028670147> ?p ?o ?g. }
- W2028670147 endingPage "590" @default.
- W2028670147 startingPage "579" @default.
- W2028670147 abstract "Angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) are some of the most commonly prescribed medications for hypertension.Most of all conventional dosage forms of ARBs and ACEIs undergo extensive first-pass metabolism, which significantly reduces bioavailability. Majority of ARBs and ACEIs are inherently short acting due to a rapid elimination half-life. In addition, oral dosage forms of ARBs and ACEIs have many high incidences of adverse effects due to variable absorption profiles, higher frequency of administration and poor patient compliance.Many attempts have been made globally at the laboratory level to investigate the skin permeation and to develop transdermal therapeutic systems of various ARBs, ACEIs and other anti-hypertensives, to circumvent the drawbacks associated with their conventional dosage form.This manuscript presents an outline of the transdermal research specifically in the area of ARBs, ACEIs and other anti-hypertensives reported in various pharmaceutical journals.The transdermal delivery has gained a significant importance for systemic treatment as it is able to avoid first-pass metabolism and major fluctuations of plasma levels typical of repeated oral administration. As we can experience from this review article that transdermal delivery of different ARBs and ACEIs improves bioavailability as well as patient compliance by many folds. In fact, the rationale development of some newer ARBs, ACEIs and other anti-hypertensives transdermal systems will provide new ways of treatment, circumventing current limitations for conventional dosage forms." @default.
- W2028670147 created "2016-06-24" @default.
- W2028670147 creator A5017365328 @default.
- W2028670147 creator A5040656999 @default.
- W2028670147 creator A5048688773 @default.
- W2028670147 creator A5089261501 @default.
- W2028670147 date "2014-07-28" @default.
- W2028670147 modified "2023-10-12" @default.
- W2028670147 title "Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension" @default.
- W2028670147 cites W1510066062 @default.
- W2028670147 cites W154942222 @default.
- W2028670147 cites W1964276790 @default.
- W2028670147 cites W1967268351 @default.
- W2028670147 cites W1968770683 @default.
- W2028670147 cites W1972456366 @default.
- W2028670147 cites W1979057166 @default.
- W2028670147 cites W1982713556 @default.
- W2028670147 cites W1984761565 @default.
- W2028670147 cites W1991691495 @default.
- W2028670147 cites W1993052853 @default.
- W2028670147 cites W1994696430 @default.
- W2028670147 cites W1997162223 @default.
- W2028670147 cites W1997876144 @default.
- W2028670147 cites W1998516754 @default.
- W2028670147 cites W2000949542 @default.
- W2028670147 cites W2003952694 @default.
- W2028670147 cites W2004824285 @default.
- W2028670147 cites W2007009569 @default.
- W2028670147 cites W2008213465 @default.
- W2028670147 cites W2010508362 @default.
- W2028670147 cites W2012373901 @default.
- W2028670147 cites W2012498986 @default.
- W2028670147 cites W2014758844 @default.
- W2028670147 cites W2015687379 @default.
- W2028670147 cites W2016490607 @default.
- W2028670147 cites W2016581182 @default.
- W2028670147 cites W2017331389 @default.
- W2028670147 cites W2019755214 @default.
- W2028670147 cites W2025371545 @default.
- W2028670147 cites W2026509374 @default.
- W2028670147 cites W2026537351 @default.
- W2028670147 cites W2028827770 @default.
- W2028670147 cites W2033172982 @default.
- W2028670147 cites W2033961812 @default.
- W2028670147 cites W2034255431 @default.
- W2028670147 cites W2038727769 @default.
- W2028670147 cites W2039740738 @default.
- W2028670147 cites W2039771892 @default.
- W2028670147 cites W2041890479 @default.
- W2028670147 cites W2042794875 @default.
- W2028670147 cites W2042860709 @default.
- W2028670147 cites W2044288340 @default.
- W2028670147 cites W2044773944 @default.
- W2028670147 cites W2044806301 @default.
- W2028670147 cites W2045527709 @default.
- W2028670147 cites W2052845991 @default.
- W2028670147 cites W2053244889 @default.
- W2028670147 cites W2054297002 @default.
- W2028670147 cites W2054945175 @default.
- W2028670147 cites W2061136592 @default.
- W2028670147 cites W2063147499 @default.
- W2028670147 cites W2066024428 @default.
- W2028670147 cites W2069549577 @default.
- W2028670147 cites W2073804396 @default.
- W2028670147 cites W2080430067 @default.
- W2028670147 cites W2084191761 @default.
- W2028670147 cites W2088324629 @default.
- W2028670147 cites W2090202564 @default.
- W2028670147 cites W2090538537 @default.
- W2028670147 cites W2095316629 @default.
- W2028670147 cites W2095549286 @default.
- W2028670147 cites W2105301879 @default.
- W2028670147 cites W2106647432 @default.
- W2028670147 cites W2107860755 @default.
- W2028670147 cites W2113832063 @default.
- W2028670147 cites W2116631824 @default.
- W2028670147 cites W2116717490 @default.
- W2028670147 cites W2140812062 @default.
- W2028670147 cites W2152701245 @default.
- W2028670147 cites W2152812065 @default.
- W2028670147 cites W2156837309 @default.
- W2028670147 cites W2157430128 @default.
- W2028670147 cites W2159996436 @default.
- W2028670147 cites W2161849510 @default.
- W2028670147 cites W2162464003 @default.
- W2028670147 cites W2162819513 @default.
- W2028670147 cites W2162936851 @default.
- W2028670147 cites W2332381288 @default.
- W2028670147 cites W4229575554 @default.
- W2028670147 cites W4230992626 @default.
- W2028670147 cites W4244359539 @default.
- W2028670147 cites W4249316425 @default.
- W2028670147 cites W4255162184 @default.
- W2028670147 cites W1975368490 @default.
- W2028670147 cites W2139029867 @default.
- W2028670147 cites W2150606591 @default.
- W2028670147 doi "https://doi.org/10.3109/10717544.2014.942444" @default.
- W2028670147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25065883" @default.